recurrence of primary aldosteronism after percutaneous ethanol injection

recurrence of primary aldosteronism after percutaneous ethanol injection

;Fan-Chi Chang;Kao-Lang Liu;Kuo-How Huang;Vin-Cent Wu;Yen-Hung Lin;Yung-Ming Chen;Kwan-Dun Wu;TAIPAI Study Group
Bioorganic & medicinal chemistry letters 2012 Vol. 111 pp. 176-178
65
chang2012journalrecurrence

Abstract

Adrenalectomy is the definite treatment for aldosterone-producing adenoma (APA). Percutaneous ethanol or acetic acid injection with computed tomography (CT) guidance has been described as a safe, noninvasive, and effective alternative treatment modality in patients with high surgical risk. We report on a man who was 49 years of age and presented with treatment-resistant hypertension and was later diagnosed with APA. CT-guided percutaneous ethanol injection (PEI) was performed for this high surgical risk patient. He had aldosteronism recurrence 4 years after the ethanol injection, so a second PEI was performed. The tumor size was reduced and his blood pressure was normalized. Therefore, we suggest that clinicians should closely check aldosterone to renin ration and potassium level if percutaneous chemical ablation is considered in functioning adrenal adenomas.

Citation

ID: 221514
Ref Key: chang2012journalrecurrence
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
221514
Unique Identifier:
10.1016/j.jfma.2012.01.009
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet